Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deutetrabenazine for Dyskinesia in Cerebral Palsy (Open RECLAIM-DCP)
NCT04200352Phase 3Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of deutetrabenazine in dyskinetic cerebral palsy (DCP), sponsored by Teva Pharmaceutical Industries Ltd.. Started Feb 2020; status: terminated.
02
Drugs
deutetrabenazine
03
Conditions
dyskinetic cerebral palsy (DCP)
Beyond the preview
Go deeper on NCT04200352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04200352.